Abnormal uterine bleeding
Not Applicable
- Conditions
- Fertility-femaletreatment of endometrial hyperplasia without atypia
- Registration Number
- PACTR201508001237608
- Lead Sponsor
- Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
no prior diagnosis of endometrial carcinoma, an intact uterus, with histologically confirmed endometrial hyperplasia (EH) without atypia
Exclusion Criteria
Women with associated pathology as uterine fibroid, cervical or vaginal pathology, bleeding tendency, chronic liver disease and any contraindications to progestin therapy were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method regression of hyperplasia after 6 months of progestin therapy.
- Secondary Outcome Measures
Name Time Method adverse effects;patient acceptability